Deals
India to Block $1.3 Billion Chinese Pharmaceutical Takeover, Sources Say
- Fosun, Gland still to be officially notified, people say
- Border spat between India, China have escalated tensions
India Said to Block Fosun's $1.3B Gland Takeover
This article is for subscribers only.
India is poised to reject Shanghai Fosun Pharmaceutical Group Co.’s proposed $1.3 billion takeover of an Indian drugmaker, according to people familiar with the matter, scuppering the biggest-ever Chinese acquisition in the country.
The Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi, has decided to block the Chinese firm’s purchase of an 86 percent stake in Gland Pharma Ltd., said the people. The companies haven’t been formally notified yet of the move, the people said, asking not to be identified because the information is private.